SLC30A10 and colorectal carcinoma: With this approach, CRC can be properly classified: the first panel (CACNA1G, LOX, SLC30A10) extracts HME using Group 1 methylated markers and the second panel (ELMO1, FBN2, THBD, HAND1 and SLC30A10 again) divides the remaining IME and LME using Group 2 markers.